TELO
Telomir Pharmaceuticals, Inc. Common Stock
NASDAQ: TELO · HEALTHCARE · BIOTECHNOLOGY
$1.40
-3.45% today
Updated 2026-04-30
Market cap
$99.72M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.33
Dividend yield
—
52W range
$1 – $3
Volume
0.1M
Telomir Pharmaceuticals, Inc. Common Stock (TELO) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | $55000.00 | $48730.00 | $4.77M | $1.32M |
| Cash & equivalents | $0.00 | $1419.00 | $1231.00 | $1.27M |
| Current assets | $0.00 | $48730.00 | $435225.00 | $1.32M |
| Total liabilities | $138131.00 | $986008.00 | $1.34M | $680968.00 |
| Current liabilities | $138131.00 | $986008.00 | $1.34M | $680968.00 |
| Long-term debt | — | — | — | — |
| Shareholder equity | $-83131.00 | $-937278.00 | $3.44M | $643037.00 |
| Retained earnings | $-138131.00 | $-992278.00 | $-14.06M | $-30.60M |
| Accounts receivable | — | — | $130000.00 | — |
| Inventory | — | — | $303281.00 | — |
| Goodwill | — | — | — | — |